FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, announced today the results of its annual general and special meeting of shareholders (“AGSM”), held online and in virtual-only format on June 29, 2023.

There were 148 shareholders represented in person or by proxy at the AGSM holding 48 Class A multiple voting shares (“Class A Shares”) and 8,176,402 Class B subordinate voting shares (“Class B Shares”), representing 66.67% and 20.94% of the votes attached to the Class A Shares and Class B Shares, respectively, with each Class A Share entitling the holder to 276,660 votes on all matters.

The detailed results of the vote for the election of directors of the Company are set out below.

Nominee	Votes For	% Votes For
Anthony Durkacz	21,442,510	99.94%
Zeeshan Saeed	21,418,876	99.83%
Dr. Lakshmi P. Kotra	18,027,894	84.02%
Adnan Bashir	18,463,181	86.05%
Nitin Kaushal	17,032,284	79.38%
Michael (Zappy) Zapolin	18,610,144	86.74%
Dr. Eric Hoskins	18,599,259	86.69%

As a result, the nominees for election as directors set out above were elected as directors of the Company to serve until the close of the next annual meeting of shareholders or until their successors are elected or appointed.

In addition, at the AGSM, the shareholders also re-appointed MNP LLP as the Company’s auditor and authorized the directors to fix the auditor’s remuneration, approved the Equity Incentive Plan originally adopted by the board on May 16, 2022, and re-approved the Stock Option Plan originally adopted by the board on February 9, 2018 and last approved by the Company’s shareholders on March 15, 2018, and approved the special resolution to amend the Company's articles of incorporation to change the name of the Company from “FSD Pharma Inc.” to such name as may be approved by the board of directors of the Company (including the changing of the Company’s stock symbol to reflect its new name) in its sole discretion, without further approval of the shareholders of the Company (the "Name Change").